Looking to sell Evozyne stock or options?
Evozyne operates a data-driven platform focused on evolution-based molecular engineering to design innovative proteins with enhanced capabilities. Their platform provides reliable models and insights into the physics of protein folding, function, and the evolutionary potential of synthetic drugs. This allows the healthcare industry to obtain tailored molecules that address specific challenges related to human health and bodily functions.
Nvidia, OrbiMed, nVentures, Fidelity Investments, Valor Equity Partners, Paragon Biosciences, NVentures (Santa Clara).